SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis
about
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomasSox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cellsParadoxical role of SOX2 in gastric cancerStomach development, stem cells and diseaseRecent progress in the study of methylated tumor suppressor genes in gastric cancerMicroscale electroporation: challenges and perspectives for clinical applications.Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.Notch as a Driver of Gastric Epithelial Cell Proliferation.Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cellsSOX2 enhances the migration and invasion of ovarian cancer cells via Src kinaseMicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomasHypermethylation of SOX2 Promoter in Endometrial Carcinogenesis.An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer.Genomic and genetic alterations influence the progression of gastric cancer.Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells.Transcriptional factor typing with SOX2, HNF4aP1, and CDX2 closely relates to tumor invasion and Epstein-Barr virus status in gastric cancerEstablishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12Parent-of-origin effects in SOX2 anophthalmia syndromeClinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.Interactions between SOX factors and Wnt/beta-catenin signaling in development and diseaseGastric cancer stem cells: evidence, potential markers, and clinical implications.Sry-box (Sox) transcription factors in gastrointestinal physiology and disease.SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer CellsClinical significance of OCT4 and SOX2 protein expression in cervical cancer.Molecular marks for epigenetic identification of developmental and cancer stem cellsSex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma.A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular Profiles.Targeted silencing of the oncogenic transcription factor SOX2 in breast cancerPredictive Value of Stemness Factor Sox2 in Gastric Cancer Is Associated with Tumor Location and Stage.CpG island hypermethylation in gastric carcinoma and its premalignant lesions.SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours.The role of Sox genes in lung morphogenesis and cancer.SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer
P2860
Q21562575-5EA6FF18-671C-43B4-AFC4-E7000B92C628Q24657573-C3B7A2B2-BDEE-4CD3-B344-EEDC35D32A21Q26749130-C59EA91A-7F6E-4624-827D-A368EDF3CA82Q26765411-CB82CF83-DC82-42A0-8977-FAE160B808D0Q27009359-B6FF9AAE-8A9D-4C24-8C0C-E6D5926EE2DBQ30449429-E1BA3975-CC7E-47EA-9B20-03FD9E0604ACQ33509293-5C57B245-6D51-4702-A472-A0476DAEFB23Q33600442-46164502-9732-4FCF-8A3A-95F48BFA2F58Q33735351-AF39D628-71FB-4CBC-9836-DF483138CEAFQ33768815-EBECE175-997A-45DB-8CFE-B74EF296D6ADQ33815238-66CB669E-089C-4EC5-8872-8B08764C49D3Q34070508-0C49871A-769D-4BC2-8489-15905DC1C5ECQ34089736-A9BDD19F-C1BA-450D-8A69-76D56371A6C2Q34174419-D777B3A8-9BE8-400E-A09F-F671FA864F67Q34220910-DFA13519-51A9-49C1-A5BE-FB02F82CFBC0Q34410160-3A63B5BB-91F3-4352-B1A5-D831E6C352B5Q34432882-2B6F4C80-1CF4-45F0-88EE-EE9F3F138B88Q34497423-8699E2E9-7967-4D54-A88E-14BEC76F6F77Q34603186-4D60D375-BCEB-4120-8A07-6FF7B4D26B98Q34766905-D19F1463-BB86-469E-897A-AE500EB75F21Q35167913-2C01178D-652B-44A2-84E9-33D6432C0D2EQ35608003-EA0D07E0-E5A2-4EC2-9D74-4FA91B599B3BQ35677409-D96CA56A-6E66-4D24-AB2E-E14299DBE701Q35719925-9E63FBEF-1918-4B4B-A040-DB7A75C9E01DQ35795934-D97A1CB1-1428-45ED-B79D-66A36753C020Q35825854-61CF6F0A-6E91-4DF1-AFA0-BDF245F17EA6Q35833703-8AC6F9CF-B2CA-4F3B-8159-D34C08C36C56Q35860804-DFB4062A-D836-4D72-B439-7E6DF81A7494Q35875807-A0CF95ED-5054-4F28-B518-9E76A7DC5385Q35878793-52868648-2C94-463D-A156-FCE90CA3F23DQ36001860-DAE5ECFA-C5D0-40F6-AB8A-074C4E8AAB3EQ36028245-AE58A9B6-E8C9-4EF3-8122-6B4F7C0CDA38Q36061775-C6F58161-06D6-4B66-B3E6-3C8B107BF8DCQ36144913-8B2B8DA9-4005-4116-A509-DEAEE9770788Q36238275-515DB5AA-858C-4096-9A6C-ECEFFB12D533Q36343388-290C7E88-1C7B-477B-BCF9-BC3A513F0339Q36365816-06C27F53-8FFE-4E21-BBAE-09424592BD27Q36538306-64EBA135-C423-466A-B595-5A4D713AD11AQ36548775-5B6B6208-297B-4A3D-B877-5A5F7C3DA535Q36732896-E87310F2-B4EB-4439-A4AF-FB1EFE7727AF
P2860
SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@ast
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@en
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@en-gb
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@nl
type
label
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@ast
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@en
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@en-gb
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@nl
prefLabel
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@ast
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@en
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@en-gb
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@nl
P2093
P2860
P921
P3181
P356
P1476
SOX2 is frequently downregulat ...... ell-cycle arrest and apoptosis
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6604193
P407
P577
2008-02-26T00:00:00Z
P5875
P6179
1048878556